Krystal Biotech KRYS
NASDAQ KRYS
$357.99 -13.48 (-3.63%)
As of: Sep 4, 2026 · 3:59 PM EDT

Krystal Biotech (KRYS) Invested Capital (2016 - 2017)

Analysis

Krystal Biotech (KRYS) Invested Capital (2016 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Krystal Biotech 10.61 Bn 9.76 Bn 112.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 49.47 Mn
Sep 30, 2017 50.20 Mn
Dec 31, 2016 987,000.00